arrow
N

Natalia Klimowska-Nassar

imperial college london
H指数:7
被引数:295

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial

联合细胞减灭术、放射治疗或消融术治疗原发性转移性前列腺癌:IP2-ATLANTA内部试点,II期,随机对照试验

2025-06-010
OAAI
Prostate Pathway Embedded Comparative Trial: Outcomes from the Pilot Phase of the Imperial Prostate 3—PROState Pathway Embedded Comparative Trial

前列腺通路嵌入式比较试验:帝国前列腺3—PRO前列腺通路嵌入式比较试验试点阶段的结果

2025-06-010
OAAI
Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study

新诊断转移性前列腺癌患者对细胞减灭治疗的偏好:IP5-MATTER研究

2024-07-010
OAAI
Prostagram magnetic resonance imaging in a screening population: Prostate Imaging-Reporting and Data System or Likert?

筛查人群中的前列腺素磁共振成像: 前列腺成像-报告和数据系统或Likert?

2023-10-160
OAAI
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study

结合使用磁共振成像和前列腺特异性抗原对筛查途径的评估: IP1-PROSTAGRAM研究的结果

2023-06-0110
OA
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study

与PSA和超声相比,MRI的感知患者负担和可接受性: IP1-PROSTAGRAM研究的结果

2023-03-310
OAAI
Direct mail from primary care and targeted recruitment strategies achieved a representative uptake of prostate cancer screening

来自初级保健的直邮和有针对性的招募策略实现了前列腺癌筛查的代表性吸收

2022-09-011
OA
Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial

十二指肠空肠旁路衬垫治疗2型糖尿病和肥胖的多中心随机对照试验

2021-06-1526
OAAI
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

十二指肠-空肠旁路衬里对脂质分布和长链多不饱和脂肪酸的血液浓度的影响

2021-04-0114
OAAI